Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
暂无分享,去创建一个
S. Neubauer | P. Traber | R. Banerjee | C. Kelly | M. Kelly | S. Harrison | A. Dennis | A. Paredes | M. Fiore | J. Whitehead | Jennifer M Whitehead